Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-26 @ 3:22 AM
Study NCT ID:
NCT03965494
Status:
TERMINATED
Last Update Posted:
2024-02-08
First Post:
2019-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-24
First Submit QC Date:
None
Study First Post Date:
2019-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-07
Last Update Post Date:
2024-02-08
Last Update Post Date Type:
ACTUAL